Probiotic for High Altitude Acclimatization
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether the probiotic SLAB51 can help people acclimate better to high altitudes by improving blood oxygen levels. Participants will take either the probiotic or a placebo (a non-active substance) during two separate stays at a high-altitude research center. Researchers will monitor various health metrics, including oxygen saturation, heart rate, and sleep quality. People who are generally healthy, haven't traveled above 2,500 meters recently, don't smoke, and have no chronic diseases might be a good fit for this study.
As an unphased trial, this study offers a unique opportunity to contribute to scientific understanding and potentially benefit from improved acclimation to high altitudes.
Will I have to stop taking my current medications?
Yes, you will need to stop taking certain medications that could affect the study's measurements, like ibuprofen, blood pressure medications, and sleep aids. If you're on any of these, you might not be able to participate.
What prior data suggests that the probiotic SLAB51 is safe for high-altitude acclimatization?
Research shows that SLAB51, a probiotic with multiple strains, is generally safe for people. In past studies, SLAB51 improved oxygen levels and reduced symptoms of Acute Mountain Sickness (AMS) at high altitudes. While these results are encouraging, no major reports of side effects or harmful reactions have emerged. This indicates that people taking SLAB51 usually did not experience discomfort or negative effects. As a probiotic, SLAB51 is similar to the beneficial bacteria found in some foods and supplements, which are often safe for many people. However, considering personal health and consulting a healthcare provider before joining any trial is always advisable.12345
Why are researchers excited about this trial?
Researchers are excited about SLAB51 for high altitude acclimatization because it uses a unique approach involving probiotics. Unlike standard treatments that might focus on medications like acetazolamide, which helps by changing the blood's acidity to improve breathing, SLAB51 introduces a massive dose of beneficial bacteria, around 800 billion per serving, to potentially support the body's natural adjustment to high altitudes. This method is groundbreaking as it seeks to leverage gut health to enhance acclimatization, potentially offering a more natural and holistic alternative to traditional drugs.
What evidence suggests that SLAB51 might be an effective treatment for high-altitude acclimatization?
Research shows that the probiotic SLAB51, which participants in this trial may receive, may help people adjust to high altitudes. Studies have found that it increases oxygen levels in the body both during the day and at night, which is important in areas with thinner air. SLAB51 also reduces symptoms of Acute Mountain Sickness (AMS), easing altitude adjustment. It appears to improve breathing, allowing the body to take in more oxygen. These findings suggest that SLAB51 might make high-altitude trips more comfortable and safer.15678
Are You a Good Fit for This Trial?
This trial is for people who are healthy but want to see if a probiotic called SLAB51 helps with getting used to high altitudes. Participants will take the probiotic or a placebo before and during stays at a high-altitude research station.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Measurement
Participants complete baseline measurements at sea level, including physiological and cognitive assessments
First Acclimatization Period
Participants take SLAB51 or placebo three times daily during a three-night acclimatization period at high altitude, with physiological and cognitive assessments
Washout Period
A washout period of at least six weeks between acclimatization periods
Second Acclimatization Period
Participants take the alternate treatment (SLAB51 or placebo) during a second three-night acclimatization period at high altitude, with repeat assessments
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments at sea level
What Are the Treatments Tested in This Trial?
Interventions
- SLAB51
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Diego
Lead Sponsor